產品詳情
僅用于工業(yè)應用或科學研究,不可用于人類或動物的臨床診斷或治療,非藥用. Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab shows antitumor activity and has potential application in non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL)